“This is aligned to our commitment of meeting the needs of NDM patients by creating tailor-made solutions for each market, working with health authorities, healthcare providers, patient advocacy groups to help patients suffering from myotonia diseases,” said Fabrice Egros, President Corporate Development and Growth Markets, Lupin.
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66f6f20207c34c7186238930554bdee8&url=https%3A%2F%2Fwww.ndtvprofit.com%2Fbusiness%2Flupin-subsidiary-partners-with-celnova-pharma-for-drug-distribution-in-latin-america&c=11530878924036633612&mkt=en-us
Author :
Publish date : 2024-09-27 06:45:00
Copyright for syndicated content belongs to the linked Source.